Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ellenbogen, K. A.
space
  arrow  Kontos, H. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Management of Refractory Neurocardiogenic Syncope

right arrow Kenneth A. Ellenbogen, MD; Mark A. Wood, MD; and Hermes A. Kontos, MD, PhD

1 January 1998 | Volume 128 Issue 1 | Page 73


TO THE EDITOR:

Therapy for neurally mediated syncope and related syndromes has recently received considerable attention. Few randomized trials of any specific therapeutic agents have been performed. ß-blockers, mineralocorticoids, theophylline, serotonin receptor blockers, disopyramide, and peripheral vasoconstrictors ({alpha}-agonists) have all been used with some success [1]. There still remains, however, a group of patients whose condition is refractory to medical and pacing therapy. We describe four patients with refractory, disabling neurocardiogenic syncope whose symptoms improved markedly after therapy with diphenylhydantoin and carbamazepine after drug or pacemaker therapy had failed.

The clinical characteristics and drug levels associated with suppression of recurrent syncope are summarized in the (Table 1). Three patients had a tumor of the neck region, and one had previously undergone neck surgery. We hypothesize that the glossopharyngeal nerve or carotid body may act as a trigger for activation of vagal afferents to the brainstem, leading to a mixed vasodepressor and vasoinhibitory response similar to that seen in patients with neurally mediated syncope and its variants. We speculate that these agents may be effective because of the inhibitory effect of carbamazepine and diphenylhydantoin on brainstem activity, although the actual level of the reflex arc affected by these drugs is not known [2, 3]. The exact mechanism by which these agents suppress the autonomic reflex involving syncope is unknown.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical Characteristics and Drug Levels in Patients with Suppression of Recurrent Syncope*

 


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Medical College of Virginia; Richmond, VA 23298


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Morillo CA, Brignole M, Wood MA, Ellenbogen KA. Management of head-up tilt induced neurocardiogenic (vasovagal) syncope. Pacing Clin Electrophysiol. [In press].

2. Ellenbogen KA, Morillo CA, Smith ML, Wood MA, Gilligan DM, Eckberg DL, et al. Neural monitoring of vasovagal syncope. Pacing Clin Electrophysiol. 1997; 20:788-94.

3. Taylor PH, Gray K, Bicknell PG, Rees JR. Glossopharyngeal neuralgia with syncope. J Laryngol Otol. 1977; 91:859-68.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
E. J Parks and M. K Hellerstein
Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms1
Am. J. Clinical Nutrition, February 1, 2000; 71(2): 412 - 433.
[Abstract] [Full Text] [PDF]


box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ellenbogen, K. A.
space
  arrow  Kontos, H. A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online